Real-time enrollment status for this crohn's disease clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 7:18 AM UTC
| NCT Number | NCT06456593 |
| Recruiting Status | Recruiting |
| Condition | Crohn's Disease |
| Phase | Clinical Trial |
| Target Enrollment | 212 participants |
| Active Locations | 43 sites in the US |
| Sponsor | Abivax S.A. |
| Last Updated on CT.gov | September 18, 2025 (Sep 18, 2025) |
As of March 2, 2026: Clinical trial NCT06456593 is currently recruiting participants. This clinical trial study for crohn's disease is actively seeking new participants at 43 locations across the United States. The study is sponsored by Abivax S.A.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06456593 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 43 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06456593 was last updated Sep 18, 2025 (September 18, 2025). HelloStudys verifies this status automatically.